Cargando…
2014 EASO Position Statement on the Use of Anti-Obesity Drugs
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger GmbH
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644876/ https://www.ncbi.nlm.nih.gov/pubmed/25968960 http://dx.doi.org/10.1159/000430801 |
_version_ | 1783271812352704512 |
---|---|
author | Toplak, Hermann Woodward, Euan Yumuk, Volkan Oppert, Jean-Michel Halford, Jason C.G. Frühbeck, Gema |
author_facet | Toplak, Hermann Woodward, Euan Yumuk, Volkan Oppert, Jean-Michel Halford, Jason C.G. Frühbeck, Gema |
author_sort | Toplak, Hermann |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5644876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | S. Karger GmbH |
record_format | MEDLINE/PubMed |
spelling | pubmed-56448762017-12-04 2014 EASO Position Statement on the Use of Anti-Obesity Drugs Toplak, Hermann Woodward, Euan Yumuk, Volkan Oppert, Jean-Michel Halford, Jason C.G. Frühbeck, Gema Obes Facts Clinical Information S. Karger GmbH 2015-06 2015-05-01 /pmc/articles/PMC5644876/ /pubmed/25968960 http://dx.doi.org/10.1159/000430801 Text en Copyright © 2015 by S. Karger GmbH, Freiburg http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable tothe online version of the article only. Distribution permitted for non-commercial purposes only. |
spellingShingle | Clinical Information Toplak, Hermann Woodward, Euan Yumuk, Volkan Oppert, Jean-Michel Halford, Jason C.G. Frühbeck, Gema 2014 EASO Position Statement on the Use of Anti-Obesity Drugs |
title | 2014 EASO Position Statement on the Use of Anti-Obesity Drugs |
title_full | 2014 EASO Position Statement on the Use of Anti-Obesity Drugs |
title_fullStr | 2014 EASO Position Statement on the Use of Anti-Obesity Drugs |
title_full_unstemmed | 2014 EASO Position Statement on the Use of Anti-Obesity Drugs |
title_short | 2014 EASO Position Statement on the Use of Anti-Obesity Drugs |
title_sort | 2014 easo position statement on the use of anti-obesity drugs |
topic | Clinical Information |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644876/ https://www.ncbi.nlm.nih.gov/pubmed/25968960 http://dx.doi.org/10.1159/000430801 |
work_keys_str_mv | AT toplakhermann 2014easopositionstatementontheuseofantiobesitydrugs AT woodwardeuan 2014easopositionstatementontheuseofantiobesitydrugs AT yumukvolkan 2014easopositionstatementontheuseofantiobesitydrugs AT oppertjeanmichel 2014easopositionstatementontheuseofantiobesitydrugs AT halfordjasoncg 2014easopositionstatementontheuseofantiobesitydrugs AT fruhbeckgema 2014easopositionstatementontheuseofantiobesitydrugs |